Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 9.1B | 8.0B | 10.6B | 8.9B |
Cost of revenue | 7.3B | 6.6B | 8.4B | 7.8B |
Gross profit | 1.8B | 1.5B | 2.1B | 1.1B |
Operating expense | ||||
Research & development | 282M | 239M | 265M | 243M |
Selling general and admin | 1.2B | 1.2B | 1.3B | 1.2B |
Other operating expenses | — | — | — | — |
Operating income | 379M | 43M | 592M | -360M |
Non operating interest income | ||||
Income | 59M | 72M | 104M | 57M |
Expense | — | — | — | — |
Other income expense | 208M | 218M | 417M | 180M |
Pretax income | 645M | 332M | 1.1B | -122M |
Tax provision | 153M | 68M | 629M | -23M |
Net income | 492M | 264M | 484M | -99M |
Basic EPS | 1.9 | 0.9 | 1.8 | -0.4 |
Diluted EPS | 1.9 | 0.9 | 1.7 | -0.4 |
Basic average shares | 272M | 275M | 276M | 275M |
Diluted average shares | 276M | 279M | 280M | 275M |
EBITDA | 576M | 225M | 861M | 24M |
Net income from continuing op. | 492M | 264M | 484M | -99M |
Minority interests | 22M | -11M | 0 | 3M |
Preferred stock dividends | — | — | — | — |